Sexual problems in patients with schizophrenia;Sexuelle störungen bei menschen mit einer schizophrenen erkrankung

Psychiatrische Praxis

Volumn 36, Issue 4, 2009, Pages 160-168

  Schöttle, Daniel ^a   Kammerahl, Dürten ^a   Huber, Johannes ^b   Briken, Peer ^a   Lambert, Martin ^a   Huber, Christian G ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Compliance; First episode psychosis; Partnership; Quality of life; Sexual side effects; Sexuality

Indexed keywords

AMANTADINE; AMISULPRIDE; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; ESTROGEN; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OPIATE; PROLACTIN; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; YOHIMBINE; ZIPRASIDONE;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISTRESS SYNDROME; DYSPAREUNIA; EXTRAPYRAMIDAL SYMPTOM; HEALTH CARE PERSONNEL; HUMAN; HYPERPROLACTINEMIA; INTERNATIONAL CLASSIFICATION OF DISEASES; LIBIDO; MENTAL PATIENT; ORGASM; PATIENT COMPLIANCE; PATIENT SATISFACTION; PENIS ERECTION; PREMATURE EJACULATION; PROFESSIONAL PRACTICE; PROLACTIN BLOOD LEVEL; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; SEDATION; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUALITY; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VAGINISM; ADOLESCENT; ADULT; AGED; BLOOD; CHEMICALLY INDUCED DISORDER; CROSS-SECTIONAL STUDY; FEMALE; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; PSYCHOSEXUAL DISORDER; PSYCHOSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROLACTIN; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 68049092971     PISSN: 03034259     EISSN: 14390876     Source Type: Journal    
DOI: 10.1055/s-0028-1090206     Document Type: Review

References (94)

1. Kelly DL, Conley RR. Sexuality and schizophrenia: a review. Schizophr Bull 2004; 30: 767-779
2. Grube M, Weigand-Tomiuk H. Sexual dysfunctions in a group of psychiatric in-patients. Psychiat Prax 2002; 29: 194-200 (Pubitemid 34534737)
3. Sigusch V. Sexuelle Störungen und ihre Behandlung. Stuttgart, New York: Thieme, 2007: 107-141
4. Meston CM, Bradford A. Sexual dysfunctions in women. Annual review of clinical psychology 2007; 3: 233-256
5. WHO. ICD-10: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organisation (WHO), 1992
6. APA. Diagnostic Criteria from DSM-IV. Washington, DC: American Psychiatric Publishing, 1994
7. Beutel ME, Stöbel-Richter Y, Daig I et al. Sexuelles Verlangen und sexuelle Aktivität von Männern und Frauen über die Lebensspanne - Ergebnisse einer repräsentativen deutschen Bevölkerungsumfrage. J Reproduktionsmed Endokrinol 2008; 5: 203-211
8. Dunn KM, Jordan K, Croft PR et al. Systematic review of sexual problems: epidemiology and methodology. J Sex Marital Ther 2002; 28: 399-422
9. Nazareth I, Boynton P, King M. Problems with sexual function in people attending London general practitioners: cross sectional study. BMJ 2003; 327: 423 (Pubitemid 37046786)
10. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537-544 (Pubitemid 29081307)
11. Fortier P, Mottard JP, Trudel G et al. Study of sexuality-related characteristics in young adults with schizophrenia treated with novel neuroleptics and in a comparison group of young adults. Schizophr Bull 2003; 29: 559-572 (Pubitemid 37339390)
12. Hartmann U. Depression and sexual dysfunction: aspects of a multi-faceted relationship. Psychiat Prax 2007; 34 (Suppl. 3): S314-317 (Pubitemid 47461181)
13. Kinzl JF. Sexuality and antipsychotics. Neuropsychiatr 2008; 22: 49-50
14. Bhui K, Puffet A, Herriot P. A survey of sexual problems amongst psychiatric inpatients. Soc Psychiatry Psychiatr Epidemiol 1995; 30: 73-77
15. Smith SM, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002; 181: 49-55 (Pubitemid 34717838)
16. Kammerahl D, Schottle D, Huber CG. Sexualität und Schizophrenie. Eine Übersicht. Z Sexualforsch 2008; 21: 165-180
17. Ferguson JM. The effects of antidepressants on sexual functioning in depressed patients: a review. J Clin Psychiatry 2001; 62 (Suppl. 3): 22-34
18. Dossenbach M, Hodge A, Anders M et al. Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol 2005; 8: 195-201 (Pubitemid 40769260)
19. Cohen S, Scholz P. Sexualstörungen in der Behandlung depressiver Erkrankungen. Psychoneuro 2004; 30: 164-168
20. Pinderhughes CA, Grace EB, Reyna LJ. Psychiatric disorders and sexual functioning. Am J Psychiatry 1972; 128: 1276-1283
21. Akhtar S, Thomson JA Jr. Schizophrenia and sexuality: a review and a report of twelve unusual cases - Part II. J Clin Psychiatry 1980; 41: 166-174 (Pubitemid 10041951)
22. Lewis J, Scott E. The sexual education needs of those disabled by mental illness. Psychiatric Rehabilitation 1997; 21: 164-167 (Pubitemid 127458408)
23. Miller LJ, Finnerty M. Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders. Psychiatr Serv 1996; 47: 502-506 (Pubitemid 26141369)
24. McCann E. The expression of sexuality in people with psychosis: breaking the taboos. J Adv Nurs 2000; 32: 132-138
25. Buddeberg C, Furrer H, Limacher B. Sexual problems in schizophrenic patients treated by ambulatory care. Psychiat Prax 1988; 15: 187-191
26. Lukoff D, Gioia-Hasick D, Sullivan G et al. Sex education and rehabilitation with schizophrenic male outpatients. Schizophr Bull 1986; 12: 669-677
27. Kelly DL, Conley RR. Evaluating sexual function in patients with treatment-resistant schizophrenia. Schizophr Res 2003; 63: 195-196 (Pubitemid 36929861)
28. Raja M, Azzoni A. Sexual behavior and sexual problems among patients with severe chronic psychoses. Eur Psychiatry 2003; 18: 70-76 (Pubitemid 36528526)
29. Pfeiffer W, Kockott G, Fischl B et al. Adverse effects of long-term psychopharmacologic therapy on sexual functions. Psychiat Prax 1991; 18: 92-98
30. Aizenberg D, Zemishlany Z, Dorfman-Etrog P et al. Sexual dysfunction in male schizophrenic patients. J Clin Psychiatry 1995; 56: 137-141
31. Kinzel U, Weig W. Medikamente und ihre Nebenwirkungen auf die Sexualität. Psychoneuro 2003; 30: 53-56
32. Darves-Bornoz JM, Lemperiere T, Degiovanni A et al. Sexual victimization in women with schizophrenia and bipolar disorder. Soc Psychiatry Psychiatr Epidemiol 1995; 30: 78-84
33. Friedman S, Harrison G. Sexual histories, attitudes, and behavior of schizophrenic and "normal" women. Arch Sex Behav 1984; 13: 555-567
34. Lysaker PH, Meyer PS, Evans JD et al. Childhood sexual trauma and psychosocial functioning in adults with schizophrenia. Psychiatr Serv 2001; 52: 1485-1488
35. Rosenberg SD, Lu W, Mueser KT et al. Correlates of adverse childhood events among adults with schizophrenia spectrum disorders. Psychiatr Serv 2007; 58: 245-253 (Pubitemid 46340470)
36. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002; 63: 1121-1128
37. Peuskens J, Sienaert P, De Hert M. Sexual dysfunction: the unspoken side effect of antipsychotics. Eur Psychiatry 1998; 13 (Suppl. 1): 23s-30s (Pubitemid 28125983)
38. Nestoros JN, Lehmann HE, Ban TA. Sexual behavior of the male schizophrenic: the impact of illness and medications. Arch Sex Behav 1981; 10: 421-442
39. Bitter I, Basson BR, Dossenbach MR. Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients. Int Clin Psychopharmacol 2005; 20: 19-21 (Pubitemid 40105544)
40. Dossenbach M, Dyachkova Y, Pirildar S et al. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006; 21: 251-258 (Pubitemid 43929245)
41. Kelly DL, Conley RR. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology 2006; 31: 340-346 (Pubitemid 43261653)
42. Ghadirian AM, Chouinard G, Annable L. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J Nerv Ment Dis 1982; 170: 463-467 (Pubitemid 12051650)
43. Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol 2001; 16: 153-162 (Pubitemid 32402360)
44. Macdonald S, Halliday J, MacEwan T et al. Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study. Br J Psychiatry 2003; 182: 50-56 (Pubitemid 36132419)
45. Demyttenaere K, De Fruyt J, Sienaert P. Psychotropics and sexuality. Int Clin Psychopharmacol 1998; 13 (Suppl. 6): S35-S41
46. Hartmann U, Ruffer-Hesse C. Sexuality and pharmacotherapy. Medication-induced disorders of sexual response and pharmacotherapeutic options for the treatment of sexual dysfunctions. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 19-32
47. Mancini T, Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am 2008; 37: 67-99, viii
48. Mah PM, Webster J. Hyperprolactinemia: etiology, diagnosis, and management. Semin Reprod Med 2002; 20: 365-374
49. Bushe C, Shaw M. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics. J Psychopharmacol 2007; 21: 768-773 (Pubitemid 47437921)
50. Marken PA, Haykal RF, Fisher JN. Management of psychotropic-induced hyperprolactinemia. Clin Pharm 1992; 11: 851-856
51. Haddad PM, Hellewell JS, Wieck A. Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports. J Psychopharmacol 2001; 15: 293-295 (Pubitemid 34024248)
52. Kim KS, Pae CU, Chae JH et al. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry 2002; 63: 408-413
53. Knegtering H, van der Moolen AE, Castelein S et al. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 2003; 28 (Suppl. 2): 109-123
54. Weig W, Cohen S, Kuhn KU et al. Sexualstörungen bei stationär psychiatrisch behandelten Patienten - eine multizentrische Prävalenzstudie. (in Vorbereitung)
55. Brunelleschi S, Zeppegno P, Risso F et al. Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients. Pharmacol Res 2003; 48: 405-409 (Pubitemid 36945339)
56. Cutler AJ. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 2003; 28 (Suppl. 1): 69-82
57. Howes OD, Wheeler MJ, Pilowsky LS et al. Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. J Clin Psychiatry 2007; 68: 361-367
58. Fric M, Laux G. Prolactin Levels and Symptoms of Hyperprolactinemia in Patients Treated with Amisulpride, Risperidone, Olanzapine and Quetiapine. Psychiat Prax 2003; 30: 97-101 (Pubitemid 36791033)
59. Kleinberg DL, Davis JM, de Coster R et al. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 1999; 19: 57-61
60. Chue P, Kovacs CS. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management. Bipolar Disord 2003; 5 (Suppl. 2): 62-79 (Pubitemid 38444339)
61. Jamerson B, Ashton AK, Houser T et al. Antidepressant compliance and side effects: Results from a patient survey. New Orleans, LA: Paper presented at the annual meeting of the American Psychiatric Association, 2001
62. Olfson M, Uttaro T, Carson WH et al. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry 2005; 66: 331-338 (Pubitemid 40476756)
63. Finn SE, Bailey JM, Schultz RT et al. Subjective utility ratings of neuroleptics in treating schizophrenia. Psychol Med 1990; 20: 843-848
64. Lambert M, Conus P, Eide P et al. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry 2004; 19: 415-422 (Pubitemid 39422495)
65. Hellewell JS, Kalali AH, Langham SJ. Patient satisfaction and acceptability of long-term treatment wih quetiapine. Int J Psychiatry Clin Prae 1999; 3: 105-113
66. Fleischhacker WW, Meise U, Gunther V et al. Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatr Scand Suppl 1994; 382: 11-15 (Pubitemid 24199707)
67. Rosenberg KP, Bleiberg KL, Koscis J et al. A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther 2003; 29: 289-296 (Pubitemid 36807936)
68. Strauss B, Gross J. Psychotropic drug-induced changes in sexuality - frequency and relevance in psychiatric practice. Psychiat Prax 1984; 11: 49-55 (Pubitemid 14139399)
69. Waldinger MD, Hengeveld MW, Zwinderman AH et al. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998; 18: 274-281
70. Gregorian RS, Golden KA, Bahce A et al. Antidepressant-induced sexual dysfunction. Ann Pharmacother 2002; 36: 1577-1589
71. Mallis D, Moisidis K, Kirana PS et al. Moderate and severe erectile dysfunction equally affects life satisfaction. J Sex Med 2006; 3: 442-449
72. Laumann EO, Paik A, Rosen RC. The epidemiology of erectile dysfunction: results from the National Health and Social Life Survey. Int J Impot Res 1999; 11 (Suppl. 1): S60-S64 (Pubitemid 29505116)
73. Byerly MJ, Nakonezny PA, Fisher R et al. An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophr Res 2006; 81: 311-316 (Pubitemid 43107707)
74. Schimmelmann BG, Paulus S, Schacht M et al. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics. J Child Adolesc Psychopharmacol 2005; 15: 249-258 (Pubitemid 40734104)
75. Fan X, Henderson DC, Chiang E et al. Sexual functioning, psychopathology and quality of life in patients with schizophrenia. Schizophr Res 2007; 94: 119-127 (Pubitemid 47031603)
76. Baldwin DS. Sexual dysfunction associated with antidepressant drugs. Expert Opin Drug Saf 2004; 3: 457-470 (Pubitemid 39242720)
77. Targum SD, Dibble ED, Davenport YB et al. The Family Attitudes Questionnaire. Patients' and spouses' views of bipolar illness. Arch GenPsychiatry 1981; 38: 562-568
78. Ablon SL, Davenport YB, Gershon ES et al. The married manic. Am J Orthopsychiatry 1975; 45: 854-866
79. Rust J, Golombok S, Collier J. Marital problems and sexual dysfunction: how are they related? Br J Psychiatry 1988; 152: 629-631
80. Harvey KV, Balon R. Clinical implications of antidepressant drug effects on sexual function. Ann Clin Psychiatry 1995; 7: 189-201 (Pubitemid 26105852)
81. Raboch J. Sexual development and life of psychiatric female patients. Arch Sex Behav 1986; 15: 341-353 (Pubitemid 16060860)
82. Kockott G, Pfeiffer W. Sexual disorders in nonacute psychiatric outpatients. Compr Psychiatry 1996; 37: 56-61 (Pubitemid 26027085)
83. Weisman AG, Nuechterlein KH, Goldstein MJ et al. Controllability perceptions and reactions to symptoms of schizophrenia: a within-family comparison of relatives with high and low expressed emotion. J Abnorm Psychol 2000; 109: 167-171
84. Weig W. Diagnostics and therapy of sexual disorders. Fortschr Neurol Psychiatr 2006; 74: 665-671; quiz 672-674
85. Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull 1997; 33: 731-745 (Pubitemid 28128129)
86. Zajecka J. Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatry 2001; 62 (Suppl. 3): 35-43 (Pubitemid 32164678)
87. Weig W. Sexual dysfunctions from a neuropsychiatric perspective. Nervenarzt 2006; 77: 101-108; quiz 109
88. Malik P. Sexual dysfunction in schizophrenia. Curr Opin Psychiatry 2007; 20: 138-142
89. Gitlin M. Sexual dysfunction with psychotropic drugs. Expert Opin Pharmacother 2003; 4: 2259-2269
90. Taylor MJ, Rudkin L, Hawton K. Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials. J Affect Disord 2005; 88: 241-254 (Pubitemid 41446967)
91. Assem-Hilger E, Kasper S. Psychopharmaka und sexuelle Dysfunktion. J Neurol Neurochir Psychiatr 2005; 6: 30-36
92. Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 2004; 64: 2291-2314 (Pubitemid 39388605)
93. Kockott G. Psychotherapie sexueller Funktions- und Erlebensstö rungen. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2007; 50: 11-18
94. Hauch M Hrsg. Paartherapie bei sexuellen Störungen. Stuttgart: Thieme, 2006